302 related items for PubMed ID: 12700959
1. Long versus standard initial steroid therapy for children with the nephrotic syndromeA report from the Southwest Pediatric Nephrology Study Group.
Lande MB, Gullion C, Hogg RJ, Gauthier B, Shah B, Leonard MB, Bonilla-Felix M, Nash M, Roy S, Strife CF, Arbus G.
Pediatr Nephrol; 2003 Apr; 18(4):342-6. PubMed ID: 12700959
[Abstract] [Full Text] [Related]
2. Long versus standard initial prednisolone therapy in children with idiopathic nephrotic syndrome.
Paul SK, Muinuddin G, Jahan S, Begum A, Rahman MH, Hossain MM.
Mymensingh Med J; 2014 Apr; 23(2):261-7. PubMed ID: 24858152
[Abstract] [Full Text] [Related]
3. Corticosteroid therapy for nephrotic syndrome in children.
Hodson EM, Knight JF, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2001 Apr; (2):CD001533. PubMed ID: 11405997
[Abstract] [Full Text] [Related]
4. Corticosteroid therapy for nephrotic syndrome in children.
Hodson EM, Knight JF, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2000 Apr; (4):CD001533. PubMed ID: 11034723
[Abstract] [Full Text] [Related]
5. Lower prednisone dosing for steroid-sensitive nephrotic syndrome relapse: a prospective randomized pilot study.
Borovitz Y, Alfandary H, Haskin O, Levi S, Kaz S, Davidovits M, Dagan A.
Eur J Pediatr; 2020 Feb; 179(2):279-283. PubMed ID: 31728673
[Abstract] [Full Text] [Related]
6. Corticosteroid therapy for nephrotic syndrome in children.
Hodson EM, Knight JF, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2004 Feb; (2):CD001533. PubMed ID: 15106158
[Abstract] [Full Text] [Related]
7. Corticosteroid therapy for nephrotic syndrome in children.
Hodson EM, Knight JF, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2003 Feb; (1):CD001533. PubMed ID: 12535410
[Abstract] [Full Text] [Related]
8. Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie.
Ehrich JH, Brodehl J.
Eur J Pediatr; 1993 Apr; 152(4):357-61. PubMed ID: 8482290
[Abstract] [Full Text] [Related]
9. Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie.
Lancet; 1988 Feb 20; 1(8582):380-3. PubMed ID: 2893190
[Abstract] [Full Text] [Related]
10. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
Li X, Tian J, Wu J, He Q, Li H, Han F, Li Q, Chen Y, Ni Q, Chen J.
Clin Ther; 2009 Apr 20; 31(4):741-50. PubMed ID: 19446147
[Abstract] [Full Text] [Related]
11. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
Przegl Lek; 2006 Apr 20; 63 Suppl 3():44-8. PubMed ID: 16898486
[Abstract] [Full Text] [Related]
12. Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome.
Bagga A, Hari P, Srivastava RN.
Pediatr Nephrol; 1999 Nov 20; 13(9):824-7. PubMed ID: 10603129
[Abstract] [Full Text] [Related]
13. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases.
Zhonghua Er Ke Za Zhi; 2014 Mar 20; 52(3):194-200. PubMed ID: 24824389
[Abstract] [Full Text] [Related]
14. [Management of idiopathic nephrotic syndrome in childhood].
Peco-Antić A.
Srp Arh Celok Lek; 2004 Mar 20; 132(9-10):352-9. PubMed ID: 15794060
[Abstract] [Full Text] [Related]
15. Corticosteroid therapy for nephrotic syndrome in children.
Hodson EM, Knight JF, Willis NS, Craig JC.
Cochrane Database Syst Rev; 2005 Jan 25; (1):CD001533. PubMed ID: 15674881
[Abstract] [Full Text] [Related]
16. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children.
Raja K, Parikh A, Webb H, Hothi D.
Pediatr Nephrol; 2017 Jan 25; 32(1):99-105. PubMed ID: 27677978
[Abstract] [Full Text] [Related]
17. Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease?
Gulati S, Godbole M, Singh U, Gulati K, Srivastava A.
Am J Kidney Dis; 2003 Jun 25; 41(6):1163-9. PubMed ID: 12776267
[Abstract] [Full Text] [Related]
18. Prediction of high-degree steroid dependency in pediatric idiopathic nephrotic syndrome.
Letavernier B, Letavernier E, Leroy S, Baudet-Bonneville V, Bensman A, Ulinski T.
Pediatr Nephrol; 2008 Dec 25; 23(12):2221-6. PubMed ID: 18618150
[Abstract] [Full Text] [Related]
19. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ, PREDNOS Collaborative Group.
BMJ; 2019 May 23; 365():l1800. PubMed ID: 31335316
[Abstract] [Full Text] [Related]
20. Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial.
Kainth D, Hari P, Sinha A, Pandey S, Bagga A.
Clin J Am Soc Nephrol; 2021 Feb 08; 16(2):225-232. PubMed ID: 33478976
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
